Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7022291 | 7612840 | I | 7022291-3 | 20100928 | 20100930 | EXP | US-JNJFOC-20100908683 | CENTOCOR ORTHO BIOTECH PRODUCTS, LP | YR | Y | 20100930 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7022291 | 1014808949 | PS | DOXORUBICIN HYDROCHLORIDE | 1 | INTRAVENOUS | 50718 | |||||
| 7022291 | 1014808950 | SS | BEVACIZUMAB | 2 | INTRAVENOUS | ||||||
| 7022291 | 1014808951 | SS | TEMSIROLIMUS | 2 | INTRAVENOUS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7022291 | 1014808949 | OVARIAN CANCER |
| 7022291 | 1014808950 | OVARIAN CANCER |
| 7022291 | 1014808951 | OVARIAN CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7022291 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 7022291 | INTESTINAL PERFORATION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |